Pediatrics Pharmacology

In-depth knowledge on the effects of medicines in children came to prominence in recent years due to appreciable increase in publicly funded research and government initiatives towards providing financial incentives to industry. According to NCBI published article an independent analyses of the economic cost and return to industry of the pediatric exclusivity program showed that when research was conducted on nine drugs, the cost to industry ranged from $5 to $44 million, with a median of $12.3 million. The net return ranged from $9 to $508 million, with a median of $140 million, and the ratio return cost went from -0.68 to 73.63. This shows the great potential that this field bears. The last ten years have witnessed both a significant expansion of pediatric pharmacology research and a redefinition of the roles of public and private sources in supporting such research.

    Related Conference of Pediatrics Pharmacology

    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    October 05-06, 2026

    39th World Pediatrics Conference

    Madrid, Spain
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE
    December 03-04, 2026

    11th Annual Pediatric Congress

    Madrid, Spain
    December 29-30, 2026

    35th World Congress on Clinical Pediatrics

    Edinburgh, Scotland
    March 25-26, 2027

    6th World Congress on Pediatric Cardiology

    Amsterdam, Netherlands

    Pediatrics Pharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in